Pharmaceutical Technology Europe-11-01-2009

Pharmaceutical Technology Europe
Packaging Special Feature

November 01, 2009

According to a survey conducted by Pharmaceutical Technology Europe (PTE), almost 50% of you believe that cost is the biggest limiting factor to innovation in the pharmaceutical packaging industry.

Pharmaceutical Technology Europe
Packaging Special Feature

November 01, 2009

Following years of development, DataMatrix codes are now a viable labelling solution for pharma manufacturers.

Pharmaceutical Technology Europe

GlaxoSmithKline (GSK) appointed 42 Technology (42T) to evaluate existing powder dispensing approaches that could be scaled for high speed manufacturing.

Pharmaceutical Technology Europe
Spotlight

November 01, 2009

Population ageing is an issue often discussed in the media, but its impact on all facets of life has been poorly characterized.

Pharmaceutical Technology Europe

November 01, 2009

November is finally upon us and the days are getting colder and shorter.

Pharmaceutical Technology Europe
News

November 01, 2009

A round-up of news from across the industry.

Pharmaceutical Technology Europe
Outsourcing Review

November 01, 2009

Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane.

Pharmaceutical Technology Europe
Packaging Special Feature

November 01, 2009

What trends have you witnessed in the pharmaceutical packaging industry in the last 2 years?

Talking Point
Pharmaceutical Technology Europe

November 01, 2009

Paper is no longer a sufficient format for information storage and interchange in the pharmaceutical industry; documents are inflexible and costly for production and storage.

Pharmaceutical Technology Europe
Formulation

November 01, 2009

Chronotherapeutic drug delivery systems (CRDDS) have been recognized as potentially beneficial to the chronotherapy (timeoptimized therapy) of widespread chronic diseases that display time-dependent symptoms.

Pharmaceutical Technology Europe
Ask the Expert

November 01, 2009

Mark Copley discusses the methods used for DPI testing and the challenges presented by the current regulatory framework.